Newcastle disease virus activated human peripheral blood mononuclear cells and their use in cancer therapy.
This invention provides a method for immune activation of human peripheral blood mononuclear cells (PBMC) by treatment with immunogens derived from New Castle Disease virus (NDV). The invention describes a method of activation of PBMC by NDV, the activated PBMCs produced by the inventive method as w...
| Main Authors: | , , , , |
|---|---|
| Format: | Patent |
| Published: |
2010
|
| _version_ | 1796972058661355520 |
|---|---|
| author | Mohammed Alitheen, Noorjahan Banu Lam, Han Yuen Yusoff, Khatijah Abd Aziz, Suraini Keong, Yeap Swee |
| author_facet | Mohammed Alitheen, Noorjahan Banu Lam, Han Yuen Yusoff, Khatijah Abd Aziz, Suraini Keong, Yeap Swee |
| author_sort | Mohammed Alitheen, Noorjahan Banu |
| collection | UPM |
| description | This invention provides a method for immune activation of human peripheral blood mononuclear cells (PBMC) by treatment with immunogens derived from New Castle Disease virus (NDV). The invention describes a method of activation of PBMC by NDV, the activated PBMCs produced by the inventive method as well as pharmaceutical compositions and vaccines comprising the same. Further embodiments of the invention relate to the use of NDV derived immunogens and the inventive activated PBMCs in immunetheraphy of proliferative diseases - such as cancer. The invention finally provides a method for killing target cells, preferably cancer cells, by co-culturing the target cells together with the inventive activated PBMCs.
|
| first_indexed | 2024-03-06T08:22:15Z |
| format | Patent |
| id | upm.eprints-32058 |
| institution | Universiti Putra Malaysia |
| last_indexed | 2024-03-06T08:22:15Z |
| publishDate | 2010 |
| record_format | dspace |
| spelling | upm.eprints-320582014-09-03T06:30:29Z http://psasir.upm.edu.my/id/eprint/32058/ Newcastle disease virus activated human peripheral blood mononuclear cells and their use in cancer therapy. Mohammed Alitheen, Noorjahan Banu Lam, Han Yuen Yusoff, Khatijah Abd Aziz, Suraini Keong, Yeap Swee This invention provides a method for immune activation of human peripheral blood mononuclear cells (PBMC) by treatment with immunogens derived from New Castle Disease virus (NDV). The invention describes a method of activation of PBMC by NDV, the activated PBMCs produced by the inventive method as well as pharmaceutical compositions and vaccines comprising the same. Further embodiments of the invention relate to the use of NDV derived immunogens and the inventive activated PBMCs in immunetheraphy of proliferative diseases - such as cancer. The invention finally provides a method for killing target cells, preferably cancer cells, by co-culturing the target cells together with the inventive activated PBMCs. 2010-11-30 Patent NonPeerReviewed Noorjahan Banu Mohammed Alitheen. (2010) Newcastle disease virus activated human peripheral blood mononuclear cells and their use in cancer therapy. PI2010700088. |
| spellingShingle | Mohammed Alitheen, Noorjahan Banu Lam, Han Yuen Yusoff, Khatijah Abd Aziz, Suraini Keong, Yeap Swee Newcastle disease virus activated human peripheral blood mononuclear cells and their use in cancer therapy. |
| title | Newcastle disease virus activated human peripheral blood mononuclear cells and their use in cancer therapy.
|
| title_full | Newcastle disease virus activated human peripheral blood mononuclear cells and their use in cancer therapy.
|
| title_fullStr | Newcastle disease virus activated human peripheral blood mononuclear cells and their use in cancer therapy.
|
| title_full_unstemmed | Newcastle disease virus activated human peripheral blood mononuclear cells and their use in cancer therapy.
|
| title_short | Newcastle disease virus activated human peripheral blood mononuclear cells and their use in cancer therapy.
|
| title_sort | newcastle disease virus activated human peripheral blood mononuclear cells and their use in cancer therapy |
| work_keys_str_mv | AT mohammedalitheennoorjahanbanu newcastlediseasevirusactivatedhumanperipheralbloodmononuclearcellsandtheiruseincancertherapy AT lamhanyuen newcastlediseasevirusactivatedhumanperipheralbloodmononuclearcellsandtheiruseincancertherapy AT yusoffkhatijah newcastlediseasevirusactivatedhumanperipheralbloodmononuclearcellsandtheiruseincancertherapy AT abdazizsuraini newcastlediseasevirusactivatedhumanperipheralbloodmononuclearcellsandtheiruseincancertherapy AT keongyeapswee newcastlediseasevirusactivatedhumanperipheralbloodmononuclearcellsandtheiruseincancertherapy |